23andMe Granted New FDA Clearance to Report Additional BRCA Variants
August 31, 2023 17:28 ET
|
23andMe, Inc.
510(k) clearance will allow 23andMe to report an additional 41 genetic variants in the BRCA1 and BRCA2 genes that increase risk for breast, ovarian, prostate and pancreatic cancer Many of these...
23andMe Reports FY2024 First Quarter Financial Results
August 08, 2023 16:05 ET
|
23andMe, Inc.
Reaffirmed Full Year Revenue Guidance and Raised Full Year Guidance for Net Loss and Adjusted EBITDA Deficit Webcast at 4:30 pm ET, August 8, 2023 SOUTH SAN FRANCISCO, Calif., Aug. 08,...
23andMe to Report FY2024 First Quarter Financial Results
July 25, 2023 16:05 ET
|
23andMe, Inc.
SOUTH SAN FRANCISCO, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people...
23andMe Releases New FDA-Cleared Genetic Report on Simvastatin, a Commonly Prescribed Statin
July 20, 2023 09:23 ET
|
23andMe, Inc.
23andMe is the first and only direct-to-consumer product to offer a suite of FDA-authorized pharmacogenetics reports, with medication insights Lipid-lowering statins are one of the most commonly...
23andMe Releases New Report Revealing Genetic Likelihood of Experiencing Panic Attacks
June 21, 2023 07:00 ET
|
23andMe, Inc.
SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today released a new report as part...
23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results
May 25, 2023 16:05 ET
|
23andMe, Inc.
Achieved FY2023 financial guidance FY2023 full year revenue grew 10% over prior year Webcast today, May 25, 2023 at 4:30 p.m. Eastern Time SOUTH SAN FRANCISCO, Calif., May 25, 2023 (GLOBE...
New 23andMe survey reveals nine out of ten physicians in the U.S. believe genetics play an important part of a patient’s complete health picture
May 16, 2023 07:00 ET
|
23andMe, Inc.
66 percent of doctors say genetic testing could lead to better outcomes because patients are more proactive about their health after learning about their DNA health profile 34 percent of doctors said...
23andMe to Report FY2023 Fourth Quarter and Full Year Financial Results
May 11, 2023 16:05 ET
|
23andMe Holding Co.
SOUTH SAN FRANCISCO, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, announced today that it will report...
23andMe Releases New Report Revealing Likelihood of Developing Lupus
May 09, 2023 07:00 ET
|
23andMe Holding Co.
SOUTH SAN FRANCISCO, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today released a new report on...
Reza Afkhami Joins 23andMe as Chief Corporate Development Officer
May 08, 2023 07:00 ET
|
23andMe Holding Co.
SOUTH SAN FRANCISCO, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) ("23andMe"), a leading human genetics and biopharmaceutical company, today announced the appointment of...